Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-18

Clinical Trial Update: Esketamine for the Treatment of Rett Syndrome [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) trial is evaluating esketamine for Rett syndrome, sponsored by the Children's Hospital of Fudan University; the study is currently acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esketamine (esketamine)

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Rett Syndrome | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING